Articles From: 2014/2/20 - Prima BioMed and Neopharm Group Execute Final Agreement for CVac License to 2014/2/20 - Fresh Del Monte Produce’s Board of Directors Announces Director Retirement And New Director Nominee Appointment


2014/2/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1091857&ProfileId=051205&sourceType=1 SYDNEY, AUSTRALIA --
Sign-up for 2014/2/20 - Prima BioMed and Neopharm Group Execute Final Agreement for CVac License investment picks
2014/2/20
Blucora, Inc. (NASDAQ: BCOR) today announced financial results for the fourth quarter and full year ended December 31, 2013.
Sign-up for 2014/2/20 - Blucora Announces Fourth Quarter and Full Year 2013 Results investment picks
2014/2/20
http://media.marketwire.com/attachments/201401/219885_NEWCOVANTALOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1091803&ProfileId=051205&sourceType=1 MORRISTOWN, NJ --
Sign-up for 2014/2/20 - Covanta Holding Corporation Announces Pricing of Senior Notes Due 2024 investment picks
2014/2/20
MOUNTAIN VIEW, Calif.
Sign-up for 2014/2/20 - Alexza Pharmaceuticals' Corporate Presentation to be Webcast from Two Upcoming March Investor Conferences investment picks
2014/2/20
By Corrie Driebusch A Beverly Hills-based brokerage team has joined UBS AG's (UBS, UBSN.VX) wealth-management arm from Bank of America Corp.'s (BAC) Merrill Lynch.
Sign-up for 2014/2/20 - Beverly Hills Broker Team Joins UBS From Merrill --Street Moves investment picks
2014/2/20
Acacia Research Corporation (1) (Nasdaq: ACTG) today reported results for the three months and year ended December 31, 2013.
Sign-up for 2014/2/20 - Acacia Research Reports Fourth Quarter and Year End Financial Results and Announces Payment of Quarterly Dividend investment picks
2014/2/20
The New York Times Company’s Board of Directors today declared a regular quarterly dividend of $.04 per share on the Company’s Class A and Class B common stock.
Sign-up for 2014/2/20 - The New York Times Company Declares Regular Quarterly Dividend investment picks
2014/2/20
NORTHBROOK, Ill.
Sign-up for 2014/2/20 - Allstate Announces Preferred Stock Dividends investment picks
2014/2/20
SAN FRANCISCO , Feb.
Sign-up for 2014/2/20 - PG&E Appoints Sumeet Singh as Vice President in Gas Operations investment picks
2014/2/20
Law Offices of Howard G.
Sign-up for 2014/2/20 - Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Conn’s, Inc. investment picks
2014/2/20
Anixter International Inc. (AXE), a distributor of items including wire and cable and communications and security products, is considering a sale, Bloomberg News reported Thursday, citing people with knowledge of the matter.
Sign-up for 2014/2/20 - Anixter Working With Goldman Sachs on Possible Sale -Bloomberg investment picks
2014/2/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1091883&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for 2014/2/20 - Con Edison Reports 2013 Earnings investment picks
2014/2/20
By MarketWatch Express Scripts says earnings, revenue dip Pharmacy benefit manager Express Scripts Holding Co.(ESRX)on Thursday said fourth-quarter net income was $501.9 million, or 63 cents a share, compared with $504.1 million, or 61 cents a share, for the same period a year ago.
Sign-up for 2014/2/20 - UPDATE: Updates, advisories and surprises investment picks
2014/2/20
Regal Lifestyle Communities Inc. Announces Results for the Quarter and Year Ended December 31, 2013 Canada NewsWire TORONTO , Feb.
Sign-up for 2014/2/20 - Regal Lifestyle Communities Inc. Announces Results for the Quarter and Year Ended December 31, 2013 investment picks
2014/2/20
Nordstrom Inc. said its fiscal fourth-quarter earnings fell 6% as the high-end department-store operator was hurt by higher overhead costs and weaker margins.
Sign-up for 2014/2/20 - Nordstrom Profit Falls 6% on Higher Costs investment picks
2014/2/20
Trading Symbol: "TESO" on NASDAQ HOUSTON , Feb.
Sign-up for 2014/2/20 - Tesco Corporation Response to White Eagle Partners, LLC Open Letter to Chairman investment picks
2014/2/20
FRANKFURT--The following is a summary of analysts' forecasts for BASF SE (BAS.XE) fourth-quarter results, based on a poll of 11 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released February 25.
Sign-up for 2014/2/20 - BASF SE 4Q 2013 -- forecast investment picks
2014/2/20
Sypris Electronics, LLC, a subsidiary of Sypris Solutions, Inc. (Nasdaq/NM: SYPR), announced today that its President, John Walsh, has been invited to speak at the RSA Conference 2014 to be held on February 24-27, 2014, in San Francisco.
Sign-up for 2014/2/20 - Sypris’ John Walsh Briefing New Organizational Strategies for Cyber Defense at RSA Conference investment picks
2014/2/20
Agreement provides broad coverage under Microsoft's patent portfolio to manufacturer of cellular technologies REDMOND, Wash.
Sign-up for 2014/2/20 - Microsoft and Hop-on Sign Patent Agreement for Android and Chrome Devices investment picks
2014/2/20
PRINCETON JUNCTION, N.J., Feb.
Sign-up for 2014/2/20 - MISTRAS Group to Present at Stifel Industrials Conference investment picks
2014/2/20
MALVERN, Pa.
Sign-up for 2014/2/20 - Endo to Announce Fourth Quarter 2013 Financial Results on February 28, 2014 investment picks
2014/2/20
SAN FRANCISCO (MarketWatch) -- Apple Inc. (AAPL) shares were off by 1.2%, or $6.44, at $530.87 Thursday as Barclays analyst Ben Reitzes cut his rating on the company to equal weight, or neutral, from overweight.
Sign-up for 2014/2/20 - Apple shares off as Barclays cuts rating investment picks
2014/2/20
Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the Cowen and Company 34 th Annual Healthcare Conference in Boston, MA on Tuesday, March 4, 2014 at 9:20 a.m. Eastern Time.
Sign-up for 2014/2/20 - Sarepta Therapeutics to Present Company Overview at the Cowen and Company 34th Annual Healthcare Conference investment picks
2014/2/20
Pebblebrook Hotel Trust (NYSE: PEB) (the “Company”) today reported results for the fourth quarter and year ended December 31, 2013.
Sign-up for 2014/2/20 - Pebblebrook Hotel Trust Reports 2013 Results investment picks
2014/2/20
The HealthLogix™ platform now combines community-wide interoperability with real-time clinical analytics to deliver better outcomes SAN JOSE, Calif.
Sign-up for 2014/2/20 - Certify Data Systems Launches Next Generation Population Health Platform at HIMSS14 investment picks
2014/2/20
CAMBRIDGE, Mass., Feb.
Sign-up for 2014/2/20 - Merrimack Announces Timing of Fourth Quarter 2013 Investor Conference Call investment picks
2014/2/20
Levi & Korsinsky commenced an investigation the Board of Directors of Emeritus Corp.
Sign-up for 2014/2/20 - INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of EMERITUS CORP. and Its Board of Directors In Connection With the Sale of the Company to Brookdale Senior Living Inc. investment picks
2014/2/20
The board of directors of Fresh Del Monte Produce Inc. (NYSE: FDP) announced today that Robert S.
Sign-up for 2014/2/20 - Fresh Del Monte Produce’s Board of Directors Announces Director Retirement And New Director Nominee Appointment investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2014/2/20 - Prima BioMed and Neopharm Group Execute Final Agreement for CVac License to 2014/2/20 - Fresh Del Monte Produce’s Board of Directors Announces Director Retirement And New Director Nominee Appointment
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity